HUP9801712A2 - Racemizálás ellen stabilizált, cilansetrontartalmú gyógyászati készítmények, előállításuk és a stabilizáló adalékanyagok alkalmazása - Google Patents
Racemizálás ellen stabilizált, cilansetrontartalmú gyógyászati készítmények, előállításuk és a stabilizáló adalékanyagok alkalmazásaInfo
- Publication number
- HUP9801712A2 HUP9801712A2 HU9801712A HUP9801712A HUP9801712A2 HU P9801712 A2 HUP9801712 A2 HU P9801712A2 HU 9801712 A HU9801712 A HU 9801712A HU P9801712 A HUP9801712 A HU P9801712A HU P9801712 A2 HUP9801712 A2 HU P9801712A2
- Authority
- HU
- Hungary
- Prior art keywords
- cilansetron
- stobilizing
- racemisation
- production
- pharmaceutical compositions
- Prior art date
Links
- 239000000654 additive Substances 0.000 title abstract 3
- NCNFDKWULDWJDS-OAHLLOKOSA-N cilansetron Chemical compound CC1=NC=CN1C[C@@H]1C(=O)C(C=2C=3N4CCCC=3C=CC=2)=C4CC1 NCNFDKWULDWJDS-OAHLLOKOSA-N 0.000 title abstract 3
- 229960002099 cilansetron Drugs 0.000 title abstract 3
- 230000000996 additive effect Effects 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 5
- 150000007513 acids Chemical class 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 230000006340 racemization Effects 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 241000245063 Primula Species 0.000 abstract 1
- 235000016311 Primula vulgaris Nutrition 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 150000002894 organic compounds Chemical class 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 230000006641 stabilisation Effects 0.000 abstract 1
- 238000011105 stabilization Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A találmány szerinti, hatóanyagként cilansetrőnt vagy savaddícióssóját tartalmazó szilárd és főlyékőny gyógyászati készítményekcilansetrőnracemizálódással szemben történő stabilizálásáhőz elegendőmennyiséggen valamely vízőldható savas adalékanyagőt, éspedig valamelyalábbi anyagőt tartalmaznak: 2-12 szénatőmőt tartalmaz és 1,1-4,8 elsőpKs-értékű egybázisú vagy több-bázisú szerves savak, a fentemlítetttöbb-bázisú szerves savak savanyú sói, és 1,5-7,5 közötti első pKs-értékű gyógyászatilag alkalmas több-bázisú ásványi savak. A találmány tővábbá a fenti savas adalékanyagők cilansetrőnnakgyógyászati készítményekben racemizálódással szemben történőstabilizására történő felhasználására vőnatkőzik. ŕ
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19733271 | 1997-08-01 | ||
DE19813661A DE19813661A1 (de) | 1997-08-01 | 1998-03-27 | Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron |
Publications (3)
Publication Number | Publication Date |
---|---|
HU9801712D0 HU9801712D0 (en) | 1998-09-28 |
HUP9801712A2 true HUP9801712A2 (hu) | 1999-04-28 |
HUP9801712A3 HUP9801712A3 (en) | 2001-08-28 |
Family
ID=7837672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9801712A HUP9801712A3 (en) | 1997-08-01 | 1998-07-29 | Pharmaceutical compositions containing cilansetron stabilized against racemisation, their production and use of stobilizing additive agents |
Country Status (29)
Country | Link |
---|---|
US (1) | US5977127A (hu) |
EP (1) | EP0895782B1 (hu) |
JP (1) | JP4324260B2 (hu) |
KR (1) | KR100515201B1 (hu) |
CN (1) | CN1117565C (hu) |
AR (1) | AR010178A1 (hu) |
AT (1) | ATE283706T1 (hu) |
AU (1) | AU743043B2 (hu) |
BR (1) | BR9803730A (hu) |
CA (1) | CA2244389C (hu) |
CZ (1) | CZ295072B6 (hu) |
DE (2) | DE19813661A1 (hu) |
DK (1) | DK0895782T3 (hu) |
DZ (1) | DZ2560A1 (hu) |
ES (1) | ES2234051T3 (hu) |
HK (1) | HK1017611A1 (hu) |
HU (1) | HUP9801712A3 (hu) |
ID (1) | ID20685A (hu) |
IL (1) | IL125403A (hu) |
NO (1) | NO323229B1 (hu) |
NZ (1) | NZ331083A (hu) |
PL (1) | PL191767B1 (hu) |
PT (1) | PT895782E (hu) |
RU (1) | RU2199318C2 (hu) |
SK (1) | SK284916B6 (hu) |
TR (1) | TR199801432A2 (hu) |
TW (1) | TW509570B (hu) |
UA (1) | UA62924C2 (hu) |
ZA (1) | ZA986715B (hu) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7452545B2 (en) * | 2001-11-13 | 2008-11-18 | Yu Ruey J | Oligosaccharide aldonic acids and their topical use |
PT1372611E (pt) * | 2001-03-26 | 2006-08-31 | Novartis Ag | Composicao farmaceutica compreendendo uma estaurosporina francamente soluvel em agua, um tensioactivo et um polimero soluvel em agua |
GB0216027D0 (en) * | 2002-07-10 | 2002-08-21 | Arachnova Therapeutics Ltd | New therapeutic use |
US20040048874A1 (en) * | 2001-05-22 | 2004-03-11 | Bardsley Hazel Judith | New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine |
AU2004204825B2 (en) * | 2003-01-13 | 2007-07-19 | Dynogen Pharmaceuticals, Inc. | Method of treating functional bowel disorders |
US20040147510A1 (en) * | 2003-01-13 | 2004-07-29 | Dynogen Pharmaceuticals, Inc. | Method of treating nausea, vomiting, retching or any combination thereof |
DE602004007225T2 (de) * | 2003-04-04 | 2008-03-06 | Dynogen Pharmaceuticals Inc., Waltham | Methode zur behandlung von erkrankungen der unteren harnwege |
US7820690B2 (en) * | 2004-03-19 | 2010-10-26 | Solvay Pharmaceuticals Gmbh | Method of treating or inhibiting a non-digestive tract derived abdominal disorder associated with pain using a 5-HT, receptor antagonist |
US20060293309A1 (en) * | 2005-03-28 | 2006-12-28 | Dynogen Pharmaceuticals, Inc. | Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors |
CA2733778A1 (en) | 2008-08-14 | 2010-02-18 | Hiroshi Uchida | Stabilized pharmaceutical composition |
JPWO2021100728A1 (hu) | 2019-11-20 | 2021-05-27 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3885357T2 (de) * | 1987-06-29 | 1994-03-24 | Duphar Int Res | Anellierte Indolderivate. |
DE4238553A1 (de) * | 1992-11-14 | 1994-05-19 | Kali Chemie Pharma Gmbh | Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel |
AU702594B2 (en) * | 1995-10-13 | 1999-02-25 | Duphar International Research B.V. | Process for the preparation of enantiomerically pure imidazolyl compounds |
-
1998
- 1998-03-27 DE DE19813661A patent/DE19813661A1/de not_active Withdrawn
- 1998-06-05 CN CN98109652A patent/CN1117565C/zh not_active Expired - Fee Related
- 1998-06-17 TW TW087109651A patent/TW509570B/zh not_active IP Right Cessation
- 1998-06-18 AR ARP980102904A patent/AR010178A1/es active IP Right Grant
- 1998-07-11 KR KR10-1998-0028014A patent/KR100515201B1/ko not_active IP Right Cessation
- 1998-07-15 DZ DZ980170A patent/DZ2560A1/xx active
- 1998-07-20 IL IL12540398A patent/IL125403A/en not_active IP Right Cessation
- 1998-07-22 PT PT98113643T patent/PT895782E/pt unknown
- 1998-07-22 AT AT98113643T patent/ATE283706T1/de active
- 1998-07-22 DK DK98113643T patent/DK0895782T3/da active
- 1998-07-22 ES ES98113643T patent/ES2234051T3/es not_active Expired - Lifetime
- 1998-07-22 DE DE59812317T patent/DE59812317D1/de not_active Expired - Lifetime
- 1998-07-22 EP EP98113643A patent/EP0895782B1/de not_active Expired - Lifetime
- 1998-07-23 TR TR1998/01432A patent/TR199801432A2/xx unknown
- 1998-07-24 SK SK1009-98A patent/SK284916B6/sk not_active IP Right Cessation
- 1998-07-24 NZ NZ331083A patent/NZ331083A/xx not_active IP Right Cessation
- 1998-07-27 CZ CZ19982367A patent/CZ295072B6/cs not_active IP Right Cessation
- 1998-07-28 ZA ZA986715A patent/ZA986715B/xx unknown
- 1998-07-29 RU RU98114668/14A patent/RU2199318C2/ru not_active IP Right Cessation
- 1998-07-29 HU HU9801712A patent/HUP9801712A3/hu unknown
- 1998-07-31 AU AU78630/98A patent/AU743043B2/en not_active Ceased
- 1998-07-31 US US09/126,751 patent/US5977127A/en not_active Expired - Lifetime
- 1998-07-31 BR BR9803730-7A patent/BR9803730A/pt not_active Application Discontinuation
- 1998-07-31 JP JP21707598A patent/JP4324260B2/ja not_active Expired - Fee Related
- 1998-07-31 PL PL327786A patent/PL191767B1/pl not_active IP Right Cessation
- 1998-07-31 CA CA002244389A patent/CA2244389C/en not_active Expired - Fee Related
- 1998-07-31 UA UA98074202A patent/UA62924C2/uk unknown
- 1998-07-31 NO NO19983540A patent/NO323229B1/no not_active IP Right Cessation
- 1998-08-03 ID IDP981075A patent/ID20685A/id unknown
-
1999
- 1999-06-30 HK HK99102775A patent/HK1017611A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9901319A2 (hu) | 9-Hidroxi-riszperidon zsírsavészterek vizes szuszpenziói, előállításuk és alkalmazásuk | |
BG106439A (en) | Pharmaceutical composition of improved solubility and oral absorptivity, containing benzamide derivative | |
NO20022264L (no) | Farmasoytisk blanding inneholdende tolterodin, samt anvendelse derav | |
HRP20010243B1 (en) | Compositions containing diphosphonic acids | |
EA199700201A1 (ru) | Парентеральные фармацевтические композиции, содержащие алкиламмониевые соли 2-арилпропиновых кислот | |
HUP9801712A2 (hu) | Racemizálás ellen stabilizált, cilansetrontartalmú gyógyászati készítmények, előállításuk és a stabilizáló adalékanyagok alkalmazása | |
ES2194679T3 (es) | Composiciones cosmeticas que contienen creatina, carnitina y/o acido piruvico. | |
MY130441A (en) | Solutions containing epinastin | |
SE8900828D0 (sv) | Antivirala och immunstimulerande farmaceutiska kompositioner samt foerfarande foer framstaellning av desamma | |
FI944823A0 (fi) | Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa | |
MXPA02011389A (es) | Forma de administracion farmaceutica para peptidos, procedimiento para su preparacion y aplicacion. | |
WO2002007677A3 (en) | Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder | |
BR0010225A (pt) | Composto de amida, processo para prepará-lo, composição farmacêutica compreendendo dito composto, método de tratamento e uso | |
UA40636C2 (uk) | Фармацевтична композиція для одержання стабільного порошку, яка містить як активний компонент асоціацію ацетилсаліцилової кислоти та метоклопраміду, фармацевтичний препарат у формі порошку та спосіб одержання цього препарату | |
KR950031084A (ko) | 국소용 진양(鎭洋) 조성물 | |
ATE227509T1 (de) | Inhibitor- und konservierungsmittelzusammensetzung | |
ES2000681A6 (es) | Un procedimiento para preparar nuevos compuestos de bencilpiperazina | |
PT97164A (pt) | Processo para a estabilizacao de uma preparacao que contenham o composto 4-etil-2-hidroxi-imino-5-nitro-3-hexenamida e de composicoes farmaceuticas que o contenham | |
EA200200211A1 (ru) | Фармацевтическая композиция и ее приготовление | |
AR008764A1 (es) | Sales hidratadas de n,n'-diacetilcistina, proceso para su preparacion, y composiciones terapeuticas que comprenden a dichas sales como ingredienteactivo. | |
HUP9601527A2 (hu) | Véralvadásgátló hatású peptid-aldehid-származékok és a vegyületeket tartalmazó gyógyszerkészítmények | |
ES2184285T3 (es) | Compuestos farmaceuticos que contienen diclorhidrato de cinconina. | |
DE69812059D1 (de) | Beta,beta-disubstituierte Derivate von 9-Deoxo-9a-N-ethenyl-9a-aza-9a-homoerythromycin A | |
KR870001153A (ko) | 디페녹시에틸아민 유도체가 함유된 약제조성물 및 그의 생산방법 | |
WO2002081462A8 (en) | Aminoflavone compounds, compositions, and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |